Desomedin
Desomedin is a medicine authorised by Swissmedic under authorisation number 53037. The authorisation holder is Bausch & Lomb Swiss AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 December 1994 and the authorisation is valid without a time limit. ATC code S01AX08 places the medicine in the group Ophthalmologicals.
| Authorisation number | 53037 |
|---|---|
| Name | Desomedin |
| Full name | Desomedin, Augentropfen, Lösung |
| Authorisation holder | Bausch & Lomb Swiss AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01AX08 |
| First authorisation | 29 December 1994 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Desomedin, Augentropfen, Lösung | B | 29 December 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 11 | 10 | ml | S01AX08 | 11.07.1. | B |
| 46 | 10 | ml | S01AX08 | 11.07.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Desomedin authorised in Switzerland?
Yes. Desomedin is authorised by Swissmedic under authorisation number 53037, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Desomedin have?
Desomedin is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Desomedin?
The authorisation holder is Bausch & Lomb Swiss AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.